Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cloprostenol
2. Cloprostenol Monosodium Salt
3. Estrumate
4. Ici 80,966
5. Ici-80,966
6. Ici80,966
7. Monosodium Salt, Cloprostenol
8. Oestrophan
9. Salt, Cloprostenol Monosodium
10. Sodium, Cloprostenol
1. 62561-03-9
2. 55028-72-3
3. (+)-cloprostenol Sodium
4. Estrumate
5. Cloprostenol Sodium Salt
6. D-cloprostenol Sodium Salt
7. Sodium (z)-7-((1r,2r,3r,5s)-2-((r,e)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate
8. (+)-cloprostenol (sodium Salt)
9. (+/-)-cloprostenol Sodium Salt
10. Cloprostenol Sodium, (+)-
11. 81129i41bj
12. 886sav9675
13. Ici 80,996
14. Ici 80996
15. Planate
16. Sodium;(z)-7-[(1r,2r,3r,5s)-2-[(e,3r)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate
17. Sodium;(z)-7-[(1s,2s,3s,5r)-2-[(e,3s)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate
18. Estroplan
19. Sodium Cloprostenol
20. 5-heptenoic Acid, 7-((1r,2r,3r,5s)-2-((1e,3r)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl)-3,5-dihydroxycyclopentyl)-, Sodium Salt (1:1), (5z)-
21. Ncgc00165774-02
22. Cloprostenol Sodium [usan]
23. Unii-886sav9675
24. Cloprostenol Sodium [usan:usp]
25. Einecs 259-439-3
26. Mfcd05863539
27. D-cloprostenol Sodium
28. Dsstox_cid_26500
29. Dsstox_rid_81669
30. Dsstox_gsid_46500
31. Schembl28242
32. Mls000028831
33. Bml2-g09
34. Chembl1520583
35. Dtxsid1046500
36. Unii-81129i41bj
37. Hms1361o21
38. Hms2235o09
39. Hms3268j10
40. Hms3413c18
41. Amy30120
42. Cloprostenol Sodium [mart.]
43. Ex-a1351
44. Tox21_112261
45. Cloprostenol Sodium [usp-rs]
46. Akos015967190
47. Akos024457034
48. Ac-6102
49. Cloprostenol Sodium [green Book]
50. Ncgc00159550-01
51. (+-)-sodium (z)-7-((1r*,2r*,3r*,5s*)-2-((e)-(3r*)-4-(m-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate
52. Ac-25916
53. Cloprostenol Sodium [usp Impurity]
54. Smr000058871
55. Cloprostenol Sodium [usp Monograph]
56. Cas-55028-72-3
57. (+)-16-m-chlorophenoxy Tetranor Pgf2alpha
58. C75577
59. A850969
60. J-524247
61. J-524252
62. 16-(m-chlorophenoxy)-tetranor- Prostaglandin F2alpha,sodium Salt
63. (+/-)-sodium (z)-7-((1r*,2r*,3r*,5s*)-2-((e)-(3r*)-4-(m-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate
64. (5z)-rel-7-[(1r,2r,3r,5s)-2-[(1e,3r)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-5-heptenoic Acid Monosodium Salt
65. (z)-7-[2beta-[(1e,3r)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3alpha,5alpha-dihydroxycyclopentan-1alpha-yl]-5-heptenoic Acid Sodium Salt
66. 5-heptenoic Acid, 7-((1r,2r,3r,5s)-2-((1e,3r)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, Monosodium Salt, (5z)-rel-
67. 5-heptenoic Acid, 7-((1r,2r,3r,5s)-2-((1e,3s)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-y))-3,5-dihydroxycyclopentyl)-, Sodium Salt (1:1),(5z)-rel-
68. 5-heptenoic Acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (1a(z),2b(1e,3r*),3.alpha.,5.alpha.)-, Sodium Salt, (+/-)-
69. 5-heptenoic Acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (1alpha(z),2beta(1e,3r*),3alpha,5alpha)-, Sodium Salt, (+-)-
70. 5-heptenoic Acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, Monosodium Salt, (1alpha(z),2beta(1e,3r*),3alpha,5alpha)-(+-)-
71. Sodium (1alpha(z),2beta(1e,3r*),3alpha,5alpha)-(1)-7-(2-(4-(3-chlorophenoxy)-3-hydroxybut-1-enyl)-3,5-dihydroxycyclopentyl)hept-5-enoate
72. Sodium (e)-7-((1r,2r,3r,5s)-2-((r,e)-3-(3-chlorophenoxy)-3-hydroxyprop-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate
73. Sodium (z)-rel-7-((1r,2r,3r,5s)-2-((r,e)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate
74. Sodium(z)-7-((1r,2r,3r,5s)-2-((r,e)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate
Molecular Weight | 446.9 g/mol |
---|---|
Molecular Formula | C22H28ClNaO6 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 11 |
Exact Mass | 446.1472106 g/mol |
Monoisotopic Mass | 446.1472106 g/mol |
Topological Polar Surface Area | 110 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 558 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Luteolytic Agents
Chemical compounds that cause LUTEOLYSIS or degeneration of the CORPUS LUTEUM. (See all compounds classified as Luteolytic Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : Prescription
Registration Country : Canada
CLOPROSTENOL (CLOPROSTENOL SODIUM)
Brand Name : PLANATE
Dosage Form : SOLUTION
Dosage Strength : 175MCG/2ML
Packaging : 20ML
Approval Date :
Application Number : 2137631
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
CLOPROSTENOL (CLOPROSTENOL SODIUM)
Brand Name : ESTRUMATE
Dosage Form : SOLUTION
Dosage Strength : 250MCG/ML
Packaging : 10/20/50/100ML
Approval Date :
Application Number : 2137658
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
CLOPROSTENOL (CLOPROSTENOL SODIUM)
Brand Name : CLOPROSTENOL VEYX
Dosage Form : SOLUTION
Dosage Strength : 0.25MG/ML
Packaging : 10/20/50ML
Approval Date :
Application Number : 2418037
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
CLOPROSTENOL (CLOPROSTENOL SODIUM)
Brand Name : CLOPROSTENOL VEYX SW
Dosage Form : SOLUTION
Dosage Strength : 175MCG/2ML
Packaging : 10/20/50ML
Approval Date :
Application Number : 2455595
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
CLOPROSTENOL (CLOPROSTENOL SODIUM)
Brand Name : ESTROPLAN
Dosage Form : SOLUTION
Dosage Strength : 250MCG/ML
Packaging : 20/50/100ML
Approval Date :
Application Number : 2298406
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
CLOPROSTENOL (CLOPROSTENOL SODIUM)
Brand Name : BIOESTROVET
Dosage Form : SOLUTION
Dosage Strength : 250MCG/ML
Packaging : 20/50/100ML
Approval Date :
Application Number : 2458896
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
CLOPROSTENOL (CLOPROSTENOL SODIUM)
Brand Name : BIOESTROVET SWINE
Dosage Form : SOLUTION
Dosage Strength : 87.5MCG/ML
Packaging :
Approval Date :
Application Number : 2535769
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info :
Registration Country : South Korea
Brand Name : Dinorin
Dosage Form : Injectable
Dosage Strength : 100MCG/ML
Packaging : 10ML, 30ML Vials
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Packaging : 10ML, 30ML Vials
Regulatory Info :
Dosage : Injectable
Dosage Strength : 100MCG/ML
Brand Name : Dinorin
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info :
Registration Country : South Korea
Brand Name : Dinorin SOW
Dosage Form : Injectable
Dosage Strength : 87.5MCG/ML
Packaging : 10ML, 30ML Vials
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Packaging : 10ML, 30ML Vials
Regulatory Info :
Dosage : Injectable
Dosage Strength : 87.5MCG/ML
Brand Name : Dinorin SOW
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info :
Registration Country : South Korea
Brand Name : Dinoplus
Dosage Form : Injectable
Dosage Strength : 250MCG/ML
Packaging : 4ML, 10ML, 20ML Vials
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Packaging : 4ML, 10ML, 20ML Vials
Regulatory Info :
Dosage : Injectable
Dosage Strength : 250MCG/ML
Brand Name : Dinoplus
Approval Date :
Application Number :
Registration Country : South Korea
Related Excipient Companies
Excipients by Applications
Market Place
Reply
28 Jun 2021
Reply
22 Feb 2020
Reply
06 Jan 2020
Reply
21 Jun 2021
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?